Digitalis and Verapamil in Atrial Fibrillation and Flutter. Is Verapamil Now the Preferred Agent?

Overview

Journal Drugs

Specialty Pharmacology

Date 1986 Mar 1

PMID 3519173

Citations 7

Authors

H O Klein

E Kaplinsky

Affiliations

Soon will be listed here.

Citing Articles

Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.

Hassan O, Suwaidi J, Salam A J Atr Fibrillation. 2017; 6(1):864.

PMID: 28496859 PMC: 5153068. DOI: 10.4022/jafib.864.

Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.

Patel A, Modasiya M, Shah D, Patel V AAPS PharmSciTech. 2009; 10(1):310-5.

PMID: 19296224 PMC: 2663699. DOI: 10.1208/s12249-009-9210-9.

Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study.

Busse D, Templin S, Mikus G, Schwab M, Hofmann U, Eichelbaum M Eur J Clin Pharmacol. 2006; 62(8):613-9.

PMID: 16823584 DOI: 10.1007/s00228-006-0154-7.

Influence of famotidine on verapamil pharmacokinetics in rats.

Matar K Eur J Drug Metab Pharmacokinet. 2005; 30(3):219-22.

PMID: 16250259 DOI: 10.1007/BF03190622.

Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation.

Naccarelli G, Hynes J, Wolbrette D, Bhatta L, Khan M, Luck J Curr Cardiol Rep. 2002; 4(5):418-25.

PMID: 12169239 DOI: 10.1007/s11886-002-0042-4.

References

Zipes D, Fischer J . Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog. Circ Res. 1974; 34(2):184-92. DOI: 10.1161/01.res.34.2.184. View

Opie L . Drugs and the heart. III. Calcium antagonists. Lancet. 1980; 1(8172):806-10. DOI: 10.1016/s0140-6736(80)91303-3. View

David D, Segni E, Klein H, Kaplinsky E . Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent. Am J Cardiol. 1979; 44(7):1378-82. DOI: 10.1016/0002-9149(79)90456-9. View

Rosen M, Wit A, Hoffman B . Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil. Am Heart J. 1975; 89(5):665-73. DOI: 10.1016/0002-8703(75)90514-1. View

HAGEMEIJER F . Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction. Circulation. 1978; 57(4):751-5. DOI: 10.1161/01.cir.57.4.751. View

Spurrell R, Krikler D, Sowton E . Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome. Br Heart J. 1974; 36(3):256-64. PMC: 458827. DOI: 10.1136/hrt.36.3.256. View

Gulamhusein S, Ko P, Carruthers S, Klein G . Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Circulation. 1982; 65(2):348-54. DOI: 10.1161/01.cir.65.2.348. View

Klein H, Segni E, Kaplinsky E . Paradoxic acceleration of ventricular rate after therapy with lidocaine and ajmaline. Findings in two patients with supraventricular tachyarrhythmia. Chest. 1977; 71(4):531-3. DOI: 10.1378/chest.71.4.531. View

Wolfson S, Herman M, Sullivan J, Gorlin R . Conversion of atrial fibrillation and flutter by propranolol. Br Heart J. 1967; 29(3):305-9. PMC: 459150. DOI: 10.1136/hrt.29.3.305. View

10.

Brown R, GOBLE A . Effect of propranolol on exercise tolerance of patients with atrial fibrillation. Br Med J. 1969; 2(5652):279-80. PMC: 1983196. DOI: 10.1136/bmj.2.5652.279. View

11.

Klein H, Pauzner H, Di Segni E, David D, Kaplinsky E . The beneficial effects of verapamil in chronic atrial fibrillation. Arch Intern Med. 1979; 139(7):747-9. View

12.

Ricci D, Orlick A, Reitz B, Mason J, Stinson E, Harrison D . Depressant effect of digoxin on atrioventricular conduction in man. Circulation. 1978; 57(5):898-903. DOI: 10.1161/01.cir.57.5.898. View

13.

Waxman H, Myerburg R, Appel R, Sung R . Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study. Ann Intern Med. 1981; 94(1):1-6. DOI: 10.7326/0003-4819-94-1-1. View

14.

Rosen M, Wit A, Hoffman B . Electrophysiology and pharmacology of cardiac arrhythmias. IV. Cardiac antiarrhythmic and toxic effects of digitalis. Am Heart J. 1975; 89(3):391-9. DOI: 10.1016/0002-8703(75)90090-3. View

15.

Pedersen K, Christiansen B, Kjaer K, Klitgaard N, Nielsen-Kudsk F . Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration. Clin Pharmacol Ther. 1983; 34(1):8-13. DOI: 10.1038/clpt.1983.121. View

16.

Kerber R, Goldman R, Gianelly R, Harrison D . Treatment of atrial arrhythmias with alprenolol. JAMA. 1970; 214(10):1849-54. View

17.

Klein H, Kaplinsky E . Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction. Am J Cardiol. 1982; 50(4):894-902. DOI: 10.1016/0002-9149(82)91251-6. View

18.

Tommaso C, McDonough T, Parker M, Talano J . Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil. Arch Intern Med. 1983; 143(5):877-81. DOI: 10.1001/archinte.143.5.877. View

19.

Khalsa A, Olsson S . Verapamil-induced ventricular regularity in atrial fibrillation. Effects of exercise, isoproterenol, atropine and conversion to sinus rhythm. Acta Med Scand. 1979; 205(6):509-15. View

20.

Spurrell R, Krikler D, Sowton E . Concealed bypasses of the atrioventricular mode in patients with paroxysmal supraventricular tachycardia revealed by intracardiac electrical stimulation and verapamil. Am J Cardiol. 1974; 33(5):590-5. DOI: 10.1016/0002-9149(74)90247-1. View